House of Lords clarifies obviousness test
Patent practitioners have welcomed a House of Lords ruling that clarifies the test for obviousness, saying it brings UK practice closer to that in continental Europe and should lead to more patents being upheld
On July 9, the House of Lords ruled in favour of Angiotech Pharmaceuticals in the closely watched case, Conor Medsystems Inc v Angiotech Pharmaceuticals Inc, upholding the validity of Angiotechs European patent for a paclitaxel-eluting stent and reversing the decisions...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.